Pharmacies Attack $68B Pfizer-Wyeth Deal In 9th Circ.

By Erin Marie Daly · May 10, 2011, 7:07 PM EDT

A group of pharmacies urged the Ninth Circuit on Tuesday to reinstate its challenge to Pfizer Inc.'s $68 billion merger with Wyeth, arguing the deal has resulted in higher prices and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Erin

May 19, 2011
Genentech Sues Apotex Over Generic Valcyte
May 19, 2011
CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit
May 18, 2011
Firms, Experts Allowed To Stay In AndroGel MDL
May 03, 2011
2nd Circ. Rejects Nurses Review Of Class Cert. Denial
April 27, 2011
Genzyme Sues Over Endo's Bid To Sell Generic Renvela
April 27, 2011
Asahi, Actelion Throw Final Punches In Fasudil IP Row
April 20, 2011
Novartis Targets Teva Over Myfortic Patents
April 13, 2011
HGS Fires Round 2 At Genentech Over Lupus Drug IP
April 13, 2011
MetroPlus, HHC Evade State Claims In OT Action
April 08, 2011
UK Court Shutters Merck's Cosopt Patent Fight